← Leaderboards
Vilasack Thammavongsa
Immunartes Llc
$4,706,565
Attributed
$4,706,565
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,706,565 · 1
By mechanism
N01$4,706,565 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Vaccines”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Kevin Saunders · Duke University$18,106,404
- Daniel Hunter Reirden · Westat, Inc.$16,121,731
- Jason Dickens · Duke University$12,259,409
Research focus
VaccinesAnimal ModelBacterial Drug ResistanceStability TestingStaphylococcus AureusToxicologyVaccine CandidateVaccine DevelopmentAdvanced DevelopmentCommunicable DiseasesContractsDisease OutbreaksEfficacy EvaluationEfficacy TestingEmerging Communicable DiseasesFormulationImmunogenicityResponseSafetyBiodefenseManufactureBacterial ResistanceCombating Antibiotic Resistant BacteriaStaphylococcus Aureus Infection
Grant awards (4)
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases$210,985
N01 · FY2025 · AI · contact PI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases$2,753,572
N01 · FY2024 · AI · contact PI
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION$622,929
N01 · FY2023 · AI · contact PI
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION$1,119,079
N01 · FY2022 · AI · contact PI